Gevo Inc (NASDAQ:GEVO) was the recipient of a large decline in short interest in June. As of June 30th, there was short interest totalling 319,600 shares, a decline of 9.7% from the May 30th total of 353,900 shares. Approximately 3.9% of the company’s stock are short sold. Based on an average daily trading volume, of 187,000 shares, the days-to-cover ratio is currently 1.7 days.
NASDAQ:GEVO traded up $0.02 on Friday, hitting $2.28. 122,526 shares of the company’s stock were exchanged, compared to its average volume of 174,911. The business has a 50-day simple moving average of $2.03. Gevo has a 52 week low of $1.79 and a 52 week high of $4.97. The stock has a market capitalization of $27.11 million, a P/E ratio of -0.44 and a beta of 2.76.
Gevo (NASDAQ:GEVO) last issued its quarterly earnings results on Wednesday, May 8th. The energy company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.16). The business had revenue of $6.40 million for the quarter, compared to the consensus estimate of $5.57 million. Gevo had a negative return on equity of 27.80% and a negative net margin of 101.89%. On average, analysts predict that Gevo will post -1.47 EPS for the current year.
An institutional investor recently bought a new position in Gevo stock. Wedbush Securities Inc. bought a new stake in Gevo Inc (NASDAQ:GEVO) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor bought 30,500 shares of the energy company’s stock, valued at approximately $67,000. Wedbush Securities Inc. owned 0.26% of Gevo as of its most recent filing with the SEC. Institutional investors own 8.55% of the company’s stock.
Several equities research analysts have commented on GEVO shares. Zacks Investment Research cut shares of EXACT Sciences from a “hold” rating to a “sell” rating in a research report on Tuesday, July 2nd. HC Wainwright boosted their price target on shares of Largo Resources from C$5.10 to C$5.20 in a research report on Thursday, March 28th. Finally, ValuEngine raised shares of Zynerba Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Monday, April 1st.
Gevo Company Profile
Gevo, Inc is a renewable chemicals and next generation biofuels company, which focuses on the development and commercialization of renewable alternatives to petroleum-based products. It operates through the following segments: Gevo; Gevo Development and Agri-Energy. The Gevo segment focuses in the research and development activities related to the future production of isobutanol, including the development of the firm’s proprietary biocatalysts, the production and sale of renewable jet and other fuels, the retrofit process, and the next generation of chemicals and biofuels that will be based on the company’s isobutanol technology.
Further Reading: What is the Fibonacci sequence?
Receive News & Ratings for Gevo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo and related companies with MarketBeat.com's FREE daily email newsletter.